128241-03-2Relevant articles and documents
HMG-CoA reductase inhibitors
-
, (2008/06/13)
Novel 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors are useful as antihypercholesterolemic agents and are represented by the following general structural formulae (I) and (II): STR1
Intermediates and processes for β-6-hydroxymethyl HMG-CoA reductable inhibitors
-
, (2008/06/13)
This invention discloses intermediates and a process for the preparation of 6-desmethyl-6-β-hydroxymethyl derivatives of lovastatin and analogs thereof at the 8-acyl side chain.
Intermediates for preparing HMG-CoA reductase inhibitors
-
, (2008/06/13)
A process for converting 6-carboxy to 6-hydroxymethyl mevinolin analogs and novel intermediates formed in this process are disclosed.